International Relations

Aventura Private Wealth closes its second Anduril offering, signaling a major shift as private capital floods into high-tech defense disruptors.

INRS professor Roberto Morandotti is the first in Canada to win the prestigious optics prize, recognizing breakthroughs that pave the way for quantum technologies.

Element Biosciences unveils VITARI, a high-throughput benchtop sequencer promising a $100 whole genome, challenging market giants and democratizing genomics.

Despite lower 2025 income, FHLBank Pittsburgh boosted community aid, signaling a wider trend of changing liquidity needs in the regional banking sector.

Klothea Bio's trial for a 'longevity protein' drug in Honduras pushes the boundaries of science, but raises questions about offshore research and equity.

Chelan Goonetilleke, fresh from securing top accolades at Whistler, takes the reins at the iconic Four Seasons Toronto amid a fierce luxury market.

A tech CEO's call for Apple to recognize sacred Christian names like 'Yeshua' sparks a debate on digital inclusion, corporate responsibility, and faith.

Xtreme One Entertainment's OTCQB uplist signals a new era for its XFC brand, aiming to boost investor trust and fund its 'minor league' MMA growth.

Princeton NuEnergy hires a battery industry titan to spearhead its commercial push, aiming to dominate the booming U.S. battery recycling market.

Canada's space pioneer MDA is moving into land, sea, and air defence with a new subsidiary, aiming to capture billions in spending and boost national security.

With two strategic hires from TriNetX and Canon Medical, Avandra signals an aggressive push to unlock siloed medical imaging data for research and AI.

Five Alberta First Nations launch a legal challenge against a federal-provincial deal, citing a lack of consent for the world's largest proposed CCS project.

At a major scientific conference, Seer Inc.'s Proteograph platform is taking center stage, promising deeper insights into Alzheimer's and heart disease.

New data shows an AI-driven approach is enrolling IBD patients 3.4x faster, promising to accelerate the delivery of novel therapies to those in need.

A new blood test can predict when Alzheimer's symptoms will start, years in advance. This breakthrough could revolutionize research, but raises deep ethical questions.

AS Tallink Grupp's annual profit fell sharply in 2025, a result masked by a strong fourth-quarter rebound fueled by vessel sales and a key accounting change.

The Dubai-based SPAC is separating its shares and warrants. Here's what this key move means for investors and the company's search for a merger target.

As Teladoc faces slowing growth, the virtual care giant adds insurance titan Michael Smith to its board, signaling a push for financial discipline.

An international education firm expands to Los Angeles, offering entrepreneurs a structured alternative to the chaotic, trend-driven world of digital marketing.

Flatiron Health launches a first-of-its-kind AI platform, merging data from 400,000 patients to revolutionize prostate cancer research and treatment.